Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy

被引：0
|
作者：
Karin Weissenborn
Georg Berding
Herbert Köstler
机构：
[1] Hochschule Hannover,Department of Neurology, Medizinische
[2] Medizinische,Department of Nuclear Medicine
[3] Hochschule Hannover,Department of Neuroradiology, Medizinische
[4] Hochschule Hannover,undefined
来源：
Metabolic Brain Disease | 2000年 / 15卷 / 3期
关键词：
D; dopamine receptor; dopamine transporter; hepatic encephalopathy;
D O I：
10.1007/BF02674526
中图分类号：
学科分类号：
摘要：
A patient suffering from liver cirrhosis presented with a bradykinetic-rigid syndrome suspected as Parkinson's disease. A detailed work-up of the case revealed hepatic encephalopathy as the cause of the neurological symptomatology. An alteration of striatal dopamine D2 receptor binding and dopamine re-uptake sites was demonstrated by123I-iodobenzamide (IBZM) and123I-ß-CIT single photon emission computed tomography (SPECT), respectively. It is suggested that the alteration of the dopamine re-uptake in cirrhotics may be the cause of an increased catabolism of dopamine in HE.
引用
收藏
页码：173 / 178
页数：5
相关论文
共 50 条
  • [31] Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat
    Ainsworth, K
    Smith, SE
    Zetterström, TSC
    Pei, Q
    Franklin, M
    Sharp, T
    PSYCHOPHARMACOLOGY, 1998, 140 (04) : 470 - 477
  • [32] Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study
    Francisco Lomeña
    Ana M. Catafau
    Eduard Parellada
    Miquel Bernardo
    Mireia Font
    Fernando Gutiérrez
    Javier Pavía
    Psychopharmacology, 2004, 172 : 165 - 169
  • [33] Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients:: an 123I-IBZM-SPECT study
    Lomeña, F
    Catafau, AM
    Parellada, E
    Bernardo, M
    Font, M
    Gutiérrez, F
    Pavía, J
    PSYCHOPHARMACOLOGY, 2004, 172 (02) : 165 - 169
  • [34] Dopamine D2 agonist priming in intact and dopamine-lesioned rats
    Richard M. Kostrzewa
    John P. Kostrzewa
    Przemyslaw Nowak
    Rose Anna Kostrzewa
    Ryszard Brus
    Neurotoxicity Research, 2004, 6 : 457 - 462
  • [35] Dopamine D2 and D4 receptor ligands:: relation to antipsychotic action
    Wilson, JM
    Sanyal, S
    Van Tol, HHM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 351 (03) : 273 - 286
  • [36] Association analysis between polymorphisms in the dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with cocaine dependence
    Lohoff, Falk W.
    Bloch, Paul J.
    Hodge, Rachel
    Nall, Aleksandra H.
    Ferraro, Thomas N.
    Kampman, Kyle M.
    Dackis, Charles A.
    O'Brien, Charles P.
    Pettinati, Helen M.
    Oslin, David W.
    NEUROSCIENCE LETTERS, 2010, 473 (02) : 87 - 91
  • [37] Oligomers of D2 dopamine receptorsEvidence from ligand binding
    Philip G. Strange
    Journal of Molecular Neuroscience, 2005, 26 : 155 - 160
  • [38] D2 DOPAMINE RECEPTOR DISTRIBUTION IN THE RODENT CNS USING ANTIPEPTIDE ANTISERA
    ARIANO, MA
    FISHER, RS
    SMYKRANDALL, E
    SIBLEY, DR
    LEVINE, MS
    BRAIN RESEARCH, 1993, 609 (1-2) : 71 - 80
  • [39] Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism
    Georges Vauquelin
    Sophie Bostoen
    Patrick Vanderheyden
    Philip Seeman
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2012, 385 : 337 - 372
  • [40] Spatial Frequency Selectivity Is Impaired in Dopamine D2 Receptor Knockout Mice
    Souza, Bruno Oliveira Ferreira
    Abou Rjeili, Mira
    Quintana, Clementine
    Beaulieu, Jean M.
    Casanova, Christian
    FRONTIERS IN INTEGRATIVE NEUROSCIENCE, 2018, 11
12345